Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease.

Mansur AP, Annicchino-Bizzacchi J, Favarato D, Avakian SD, César LA, Ramires JA.

Clin Cardiol. 2000 May;23(5):335-40.

2.

Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease.

de Padua Mansur A, Annicchino-Bizzacchi J, Favarato D, Avakian SD, Machado César LA, Franchini Ramires JA.

Am J Cardiol. 2000 May 1;85(9):1089-93.

PMID:
10781757
4.

Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.

Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, Allen A, Karagounis LA, Ward RH.

Circulation. 1994 Feb;89(2):567-77.

PMID:
8313545
5.
7.
8.
9.

Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients.

Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W.

Circulation. 1995 Nov 15;92(10):2796-9.

10.

The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample.

Scartezini M, Zago MA, Chautard-Freire-Maia EA, Pazin-Filho A, Marin-Neto JA, Hotta JK, Nascimento AJ, Dos-Santos JE.

Braz J Med Biol Res. 2003 Mar;36(3):369-75. Epub 2003 Mar 7.

13.

Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese.

Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, Chen WJ, Hsu TS, Kuo CT, Chiang CW, Lee YS.

Hum Genet. 1997 Aug;100(2):210-4.

PMID:
9254851
14.

Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients.

Arca M, Pannitteri G, Campagna F, Candeloro A, Montali A, Cantini R, Seccareccia F, Campa PP, Marino B, Ricci G.

Eur J Clin Invest. 1998 Jun;28(6):485-90.

PMID:
9693941
15.
16.

Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease.

Wesolowska E, Marcil M, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr.

Pathol Biol (Paris). 1998 May;46(5):295-300.

PMID:
9769888
17.

Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.

Duman BS, Türkoğlu C, Akpinar B, Güden M, Vertii A, Cağatay P, Günay D, Sevim Büyükdevrim A.

Ann Hum Biol. 2005 Sep-Oct;32(5):620-9.

PMID:
16316917
18.

Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis.

Avakian SD, Annicchino-Bizzacchi JM, Grinberg M, Ramires JA, Mansura AP.

Clin Genet. 2001 Nov;60(5):381-4.

PMID:
11903341
19.

A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study.

Mattu RK, Needham EW, Galton DJ, Frangos E, Clark AJ, Caulfield M.

Circulation. 1995 Jan 15;91(2):270-4.

20.

Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene.

Rodríguez-Pérez JC, Rodríguez-Esparragón F, Hernández-Perera O, Anabitarte A, Losada A, Medina A, Hernández E, Fiuza D, Avalos O, Yunis C, Ferrario CM.

J Am Coll Cardiol. 2001 May;37(6):1536-42.

Items per page

Supplemental Content

Write to the Help Desk